Signaling Pathway
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25016 | MD-43 | ≧98.0% |  | |
| MD-43 is a potent and selective degrader of MCT4. | ||||
| 25032 | BMS-466442 | 1598424-76-0 | ≧98.0% |  |
| BMS-466442 is a small molecule inhibitor of asc-1. | ||||
| 25033 | Azeliragon | 603148-36-3 | ≧98.0% |  |
| Azeliragon (TTP488) is an orally bioavailable small molecule inhibitor of the recepto | ||||
| 25052 | Lazertinib mesylate | 2247995-37-3 | ≧98.0% |  |
| Lazertinib is a an orally available third-generation, selective inhibitor of certain | ||||
| 25062 | GP130 modulator-1 | 2375779-31-8 | ≧98.0% |  |
| GP130 modulator-1 (compound A33) is agp130signaling pathway modulator. GP130 modulato | ||||
| 25063 | Seladelpar sodium salt | 3026272-26-1 | ≧98.0% |  |
| Seladelpar is a PPAR-delta agonist. | ||||
| 25065 | Ecopipam ( SCH 39166 ) | 112108-01-7 | ≧98.0% | _112108-01-7.png) |
| Ecopipam ( SCH 39166 ) is a Selective Dopamine Receptor D1/D5 Antagonist used in the | ||||
| 25078 | CFT1946 | 2882165-79-7 | ≧98.0% |  |
| CFT1946 is an investigational, orally bioavailable small molecule degrader of BRAF V6 | ||||
| 25089 | Irpagratinib | 2230974-62-4 | ≧98.0% |  |
| Irpagratinib is an orally bioavailable, selective inhibitor of human fibroblast growt | ||||
| 25127 | Zosuquidar ( LY-335979 ) | 167354-41-8 | ≧98.0% |  |
| Zosuquidar is a potent modulator of P-glycoprotein-mediated multi-drug resistance. | ||||